PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS

A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2007.02.010 ◽

2007 ◽

Vol 78 (1) ◽

pp. 132-135 ◽

Cited By ~ 15

Author(s):

L. Pala ◽

E. Mannucci ◽

I. Dicembrini ◽

C.M. Rotella

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Mealtime Insulin ◽

Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens

Endocrinología y Nutrición (English Edition) ◽

10.1016/j.endoen.2012.11.007 ◽

2013 ◽

Vol 60 (5) ◽

pp. 249-253

Author(s):

Irene Vinagre ◽

Juan Sánchez-Hernández ◽

José Luis Sánchez-Quesada ◽

Miguel Ángel María ◽

Alberto de Leiva ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Bolus Insulin ◽

Basal Bolus ◽

Term Type ◽

PDB24 ASSESSMENT OF THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART + METFORMIN VERSUS HUMAN INSULIN + METFORMIN REGIMENS IN TYPE-2 DIABETES IN GERMANY BASED ON THE CLINICAL FINDINGS OF THE PHAZIT STUDY

Value in Health ◽

10.1016/s1098-3015(10)67643-7 ◽

2005 ◽

Vol 8 (6) ◽

pp. A161-A162

Author(s):

S Roze ◽

KU Wittrup-Jensen ◽

C Haüser ◽

WJ Valentine ◽

AJ Palmer

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Clinical Findings

Safety and efficacy of biphasic insulin aspart 30 in type 2 diabetes patients switched from either biphasic or basal human insulin: results from the Gulf cohort of the A1chieve study

International Journal of Clinical Practice ◽

10.1111/ijcp.12391 ◽

2014 ◽

Vol 68 (7) ◽

pp. 850-856 ◽

Cited By ~ 3

Author(s):

A. Almansari ◽

S. Khader ◽

A. Kharawagh ◽

W. AbdelFattah ◽

T. Badawy

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Safety And Efficacy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Filipino cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70008-1 ◽

2013 ◽

Vol 100 ◽

pp. S35-S40 ◽

Cited By ~ 3

Author(s):

Mary Anne Lim-Abrahan ◽

Susan Yu-Gan ◽

Anand B. Jain ◽

Leorino M. Sobrepena ◽

Veronica A. Racho

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study

Current Medical Research and Opinion ◽

10.1185/030079907x253636 ◽

2007 ◽

Vol 23 (12) ◽

pp. 3209-3214 ◽

Cited By ~ 29

Author(s):

M. Shestakova ◽

S. K. Sharma ◽

M. Almustafa ◽

K. W. Min ◽

N. Ayad ◽

...

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Indonesian cohort of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70009-3 ◽

2013 ◽

Vol 100 ◽

pp. S41-S46 ◽

Cited By ~ 4

Author(s):

Pradana Soewondo ◽

Dharma Lindarto ◽

Sony Wibisono ◽

Olly Renaldi ◽

Tjokorda Gde Dalem-Pemayun

Keyword(s):

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Clinical Safety ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes

Value in Health ◽

10.1016/j.jval.2013.03.819 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

Z. Hussein ◽

A.A. Shafie ◽

K. AlRaddady ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Switching Therapy ◽

Short And Long Term

Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens

Endocrinología y Nutrición ◽

10.1016/j.endonu.2012.11.009 ◽

2013 ◽

Vol 60 (5) ◽

pp. 249-253 ◽

Cited By ~ 6

Author(s):

Irene Vinagre ◽

Juan Sánchez-Hernández ◽

José Luis Sánchez-Quesada ◽

Miguel Ángel María ◽

Alberto de Leiva ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Bolus Insulin ◽

Basal Bolus ◽

Term Type ◽

PDB63 ESTIMATING THE LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN ASPART (NOVORAPID®) FROM HUMAN SOLUBLE INSULIN IN TYPE 2 DIABETES PATIENTS IN THE POLISH SETTING

Value in Health ◽

10.1016/s1098-3015(10)65011-5 ◽

2007 ◽

Vol 10 (6) ◽

pp. A274

Author(s):

K Erny-Albrecht ◽

G Goodall ◽

S Nielsen ◽

C Townsend ◽

R Kotchie ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Outcomes ◽

Insulin Aspart ◽

Soluble Insulin ◽